Press "Enter" to skip to content

Merck gets EU panel nod for first ever Ebola vaccine

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid

(Reuters) – A panel of the European drugs regulator on Friday recommended approving Merck & Co’s vaccine for the deadly Ebola virus.

The European Medicines Agency said its human medicines committee (CHMP) has recommended granting a conditional marketing authorization in the European Union for the vaccine, Ervebo, for individuals aged 18 years and older.

Reporting by Pushkala Aripaka in Bengaluru; Editing by Saumyadeb Chakrabarty

Our Standards:The Thomson Reuters Trust Principles.